HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Supervised exercise therapy for intermittent claudication: current status and future perspectives.

Abstract
Intermittent claudication (IC) has a high prevalence in the older population and is closely associated with cardiovascular and cerebrovascular disease. High mortality rates are reported due to ongoing atherosclerotic disease. Because of these serious health risks, treatment of IC should address reduction of cardiovascular events (and related morbidity/mortality) and improvement of the poor health-related quality of life (QoL) and functional capacity. In several randomized clinical trials and systematic reviews, supervised exercise therapy (SET) is compared with non-supervised exercise, usual care, placebo, walking advice or vascular interventions. The current evidence supports SET as the primary treatment for IC. SET improves maximum walking distance and health-related QoL with a marginal risk of co-morbidity or mortality. This is also illustrated in contemporary international guidelines. Community-based SET appears to be at least as efficacious as programs provided in a clinical setting. In the Netherlands, a national integrated care network (ClaudicatioNet) providing specialized care for patients with IC is currently being implemented. Besides providing a standardized form of SET, the specialized physical therapists stimulate medication compliance and perform lifestyle coaching. Future research should focus on the influence of co-morbidities on prognosis and effect of SET outcome and the potential beneficial effects of SET combined with a vascular intervention.
AuthorsGert-Jan Lauret, Daniëlle C W van Dalen, Edith M Willigendael, Erik J M Hendriks, Rob A de Bie, Sandra Spronk, Joep A W Teijink
JournalVascular (Vascular) Vol. 20 Issue 1 Pg. 12-9 (Feb 2012) ISSN: 1708-5381 [Print] England
PMID22328620 (Publication Type: Journal Article, Review)
Topics
  • Combined Modality Therapy
  • Evidence-Based Medicine
  • Exercise Therapy
  • Exercise Tolerance
  • Humans
  • Intermittent Claudication (physiopathology, psychology, therapy)
  • Quality of Life
  • Recovery of Function
  • Treatment Outcome
  • Walking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: